[Changes in clinico-immunological indices of experimental allergic encephalomyelitis after treatment with perftoran].
Zhitnukhin
Iu L
IuL
Litvinenko
I V
IV
Bisaga
G N
GN
Odinak
M M
MM
D000818:Animals; D001323:Autoantibodies / Q000032:analysis; D001802:Blood Substitutes / Q000627:therapeutic use*; D002464:Cell Migration Inhibition; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000188:drug therapy / Q000276:immunology*; D005466:Fluorocarbons / Q000627:therapeutic use*; D006168:Guinea Pigs; D006968:Hypersensitivity, Delayed / Q000276:immunology; D004676:Myelin Basic Protein / Q000276:immunology
D001323:Autoantibodies; D001802:Blood Substitutes; D005466:Fluorocarbons; D004676:Myelin Basic Protein; C063334:perftoran
Izmenenie kliniko-immunologicheskikh pokazateleĭ éksperimental'nogo allergicheskogo éntsefalomielita pod vliianiem perftorana.